Data / Form D filings / FEMASYS INC
FEMASYS INC: Form D filings
FEMASYS INC, a biotechnology company in Suwanee, GA, filed 17 Form D notices with the SEC between 2009 and 2026. The latest, on August 20, 2026, reports $30 million sold of a $30 million offering to 41 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 3950 JOHNS CREEK COURT SUITE 100, Suwanee, GA, 30024
- Phone
- (770) 500-3910
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1339005
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Aug 20, 2026 | New notice | $30,000,000 | $30,000,000 | 41 | Aug 10, 2026 | sec.gov | |
| Nov 14, 2025 | New notice | $12,000,000 | $8,025,000 | $3,975,000 | 12 | Nov 7, 2025 | sec.gov |
| Jun 10, 2025 | New notice | $1,450,000 | $1,450,000 | 6 | Jun 2, 2025 | sec.gov | |
| Nov 22, 2023 | New notice | $6,850,000 | $6,850,000 | 4 | Nov 14, 2023 | sec.gov | |
| Jan 13, 2017 | New notice | $4,000,000 | $4,000,000 | 8 | Jan 6, 2017 | sec.gov | |
| Dec 27, 2016 | New notice | $36,628,704 | $36,628,704 | 18 | Dec 14, 2016 | sec.gov | |
| Aug 11, 2016 | New notice | $4,000,000 | $3,296,700 | $703,300 | 19 | Jul 28, 2016 | sec.gov |
| Apr 28, 2015 | New notice | $8,000,000 | $8,000,000 | 3 | Apr 16, 2015 | sec.gov | |
| Sep 23, 2013 | New notice | $4,550,000 | $180,000 | $4,370,000 | 3 | Sep 13, 2013 | sec.gov |
| Nov 27, 2012 | New notice | $3,000,000 | $30,000 | $2,970,000 | 1 | Nov 21, 2012 | sec.gov |
| Jun 8, 2012 | New notice | $6,490,000 | $1,010,000 | $5,480,000 | 2 | May 31, 2012 | sec.gov |
| Sep 20, 2011 | New notice | $10,000,000 | $1,750,000 | $8,250,000 | 1 | Sep 12, 2011 | sec.gov |
| Jun 22, 2011 | New notice | $6,000,000 | $641,502 | $5,358,498 | 14 | Feb 24, 2011 | sec.gov |
| Aug 30, 2010 | Amendment | $5,000,000 | $1,075,000 | $3,925,000 | 6 | Aug 11, 2010 | sec.gov |
| Aug 27, 2010 | New notice | $5,000,000 | $1,025,000 | $3,975,000 | 5 | Aug 11, 2010 | sec.gov |
| Jun 10, 2009 | Amendment | $4,000,000 | $1,750,000 | $2,250,000 | 4 | Jun 1, 2009 | sec.gov |
| Jun 10, 2009 | New notice | $4,000,000 | $2,240,000 | $1,760,000 | 4 | Jun 1, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Kathy Lee-Sepsick | Executive Officer, Director | |
| Dov Elefant | Executive Officer | |
| Charles Larsen | Director | |
| Alistair Milnes | Director | |
| Kenneth Eichenbaum | Director | |
| Edward R. Uzialko | Director | |
| Jeremy Sippos | Executive Officer | |
| John Canninng | Executive Officer | |
| Jeffrey Mifek | Executive Officer |
Other biotechnology companies in Georgia that filed recently
- Opus Medical Therapies, LLC $485,089 · Sep 22, 2026
- Airway Therapeutics, Inc. $43.5 million · Sep 9, 2026
Every Form D from the week of Aug 17, 2026 · All recent filings in Georgia · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what FEMASYS INC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.